Recent evidence from continuous, high-resolution in vivo tracking of cancer cells in lineage tracing mice with oncogenic Kras and p53 mutations enabled the identification of divergent cellular plasticity and evolutionary paths, distinct expression programs that expand during tumor evolution, and the formation of metastases from spatially localized, expanding subclones of the tumor [42]. The gene discussed is TP53; the disease is neoplasm.